ASAIO J 2021 Jul 27. Epub 2021 Jul 27.
From the Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany Department of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany BerlinHeals GmbH, Berlin, Germany.
Current therapies significantly improve survival and clinical endpoints in patients suffering from chronic heart failure with reduced ejection fraction (HFrEF), but most are not sufficient to reverse adverse remodeling and improve myocardial contractility. Herein, we report the first-in-man experience with a novel fully implantable device for cardiac electrical microcurrent (C-MIC) application. A 79-year-old man suffering from HFrEF (dilated cardiomyopathy, NYHA class III, left ventricular ejection fraction 30%) successfully underwent implantation of the C-MIC device through left anterolateral thoracotomy. Read More